Benedicte De Bruycker – DPC volunteer since 2015
- Actions
Benedicte, volunteer at the Demoucelle Parkinson Charity since 2015, tells us what motivates her to be a volunteer at Run for Parkinson.
Blog
Portrait of Alain Mallart, living with Parkinson’s disease since 2012
- Humans touched by Parkinson’s
Portrait of Alain Mallart, living with Parkinson’s disease since 2012. He created Action Parkinson, a patients’ association which offers Parkinson’s patients in the Brussels region the opportunity to meet and participate in various activities adapted to their pathology.
Ask the MD: Predicting How Parkinson’s Will Progress
- Research
After a Parkinson’s diagnosis, one of the first questions a person asks is, “What is going to happen to me?” People with Parkinson’s disease understandably want to know how their symptoms will change over time.
A fantastic 5th edition of Run for Parkinson
- Actions
A fantastic 5th edition of Run for Parkinson on May 19th 2019 at the occasion of the 20km of Brussels. Thank you to all our supporters!
Take a look at our photo album.
Ask the MD: Placebo and Parkinson’s
- Research
Many clinical trials use a placebo comparison to evaluate the effect of a new drug or therapy. Some people get the active intervention and some get an inactive “fake” treatment that looks the same as the real thing. What is a placebo? Is it a good thing? Can a placebo make you feel worse? From Michael J. Fox Foundation for Parkinson’s Research website.
Ask the MD: Depression and anxiety in Parkinson’s disease
- Living with Parkinson’s / Research
Doctor Rachel Dolhun is movement disorder specialist and vice president of medical communications at the MJFF. In this video, she talks about depression and anxiety in Parkinson’s disease. How are depression and anxiety treated? What are the tips to manage depression and anxiety?
Trophic Factor Study Results: Placebo Effect?
- Research
Results are in from a study of glial cell line-derived neurotrophic factor (GDNF), a “brain fertilizer” that some scientists believe may help protect dopamine cells and improve Parkinson’s symptoms. Many news reports are citing the findings as miraculous, but the response could be due to placebo effect.
Ask the MD: Gene Therapy for Parkinson’s
- Research
Gene therapy is a hot topic in Parkinson’s disease. Researchers are now testing this novel approach in clinical trials of people with mid- to late-stage Parkinson’s. These therapies are intended to treat movement symptoms, lessen levodopa needs and, in turn, limit possible medication complications.
Portrait of Piet De Vocht, living with Parkinson’s disease since 2012
- Humans touched by Parkinson’s
Piet De Vocht has Parkinson’s disease since 2012. He guides us through his experience and the transition of before and after.
New project: AC IMMUNE
- Research
We are happy to announce our support to the upcoming new phase of the pet tracer project of AC IMMUNE, a Swiss biopharmaceutical company.